All entries for: Jazz Pharmaceuticals plc

August 3, 2026

Jazz Pharmaceuticals plc

Negative Outlook

Dublin, Ireland
1,000-5,000 employees

The IRA also made several changes to the Medicare Part D benefit, including a limit on annual out-of-pocket costs and a change in manufacturer liability under the program, that could negatively affect our business and financial condition.

Disease Area: Multiple, Neurological Diseases, Oncology, Rare Diseases
Drug Type: Biologic, Small Molecule
Scroll to Top